Effectiveness of Deep Dry Needling on Muscle Tone in Healthy Subjects

October 18, 2017 updated by: University of Castilla-La Mancha

The main objective of this study is to analyze the effect of dry needling of the soleus muscle to modulate muscle tone in healthy non-injured subjects. The secondary objective is to study if effects occur due to changes in the neural or mechanical component (or both).

Hypothesis: Deep Dry Needling of the latent medial Myofascial Trigger Point (MTrP) of the soleus muscle produces changes in muscle tone varying the passive resistance torque at a rate of 180º/ s.

Study Overview

Detailed Description

Methods:

It is a double-blinded randomized clinical trial where subjects are healthy volunteers from the city of Toledo between 18 and 40 years.

There will be an intervention group (dry needling into the medial MTrP of soleus muscle) and a control group (dry needling distal to the MTrP but into the taut muscle band of soleus muscle). The intervention will be a unique session.

Intervention:

Dry needling technique will be performed by locating the taut band and the Myofascial Trigger Point. After that, a thin needle (0,32x40mm) is introduced directly into a Myofascial Trigger Point with the aims to generate a "local twitch response" that are involuntary contractions of the muscle fibers. This puncture may reproduce patient's symptoms, and causes muscle relaxation to achieve at the same time the relief of muscle tension and pain and also to recover the metabolism of the muscle.

Assessment:

The mechanical and the neural properties of muscle tone were evaluated using an isokinetic dynamometry and H-reflex test measurement, respectively Isokinetic dynamometric technique is considered a valid biomechanics method to measure muscle tone in non-injured subjects.

The H-reflex has been utilized as a probe to study neurophysiological phenomena. This measurement can be used to assess the response of the nervous system to various neurologic conditions, musculoskeletal injuries, application of therapeutic modalities, pain, exercise training, and performance of motor tasks.

Outcome measures:

Outcome measures will include passive resistive torque to ankle dorsiflexion, dorsiflexion passive range of motion (PROM), maximal isometric voluntary force (MIVF) and H-reflex and M-response measurements and they will be evaluated before, at 10 min and 1 week after the intervention.

Study Type

Interventional

Enrollment (Actual)

46

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Toledo, Spain
        • Toledo Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age range 18-40 years.
  • Healthy volunteers.
  • Presence of a latent medial MTrP of the soleus muscle.
  • Being able to provide written informed consent.
  • Being able to follow instructions and realize clinical tests.

Exclusion Criteria:

  • Any history of ipsilateral lower limb severe injury or intervention (e.g. fracture, surgical intervention).
  • Pain or musculoskeletal injury, ligament injury, tendonitis or plantar fasciitis in the ipsilateral leg for six months previous to the intervention.
  • Peripheral or central nervous system neurological disease.
  • Altered sensitivity in the treatment area.
  • Treatment of a myofascial trigger point in the sural triceps in the six months previous to the intervention.
  • Changes in physical activity which would have affected muscle tone during the study.
  • Fear of needles.
  • No tolerance to pain caused by dry needling.
  • No continuance commitment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dry Needling into MTrPs.
Intervention-Dry Needling: Deep Dry Needing into the medial Myofascial Trigger Point of the soleus muscle.

Deep Dry Needling into the site of the latent medial Myofascial Trigger Point of the soleus muscle.

1 session in soleus muscle moving the needle up and down ten times.

Active Comparator: Dry Needling out of MTrPs.
Control-Dry Needling: Deep Dry Needling distal to Myofascial Trigger Point of the soleus muscle (in the same taut band).

Deep Dry Needling distal to Myofascial Trigger Point but into the same taut band.

1 session in soleus muscle moving the needle up and down ten times.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Passive resistive torque to ankle dorsiflexion.
Time Frame: Pre-intervention (Day 1); After intervention (Day 1); Follow up (1 week after intervention).
Passive resistive torque to ankle dorsiflexion at slow (10º/s) and fast (180º/s) velocities.
Pre-intervention (Day 1); After intervention (Day 1); Follow up (1 week after intervention).
Change in Dorsiflexion passive range of motion.
Time Frame: Pre-intervention (Day 1); After intervention (Day 1); Follow up (1 week after intervention).
Soleus muscle extensibility (Dorsiflexion angle of ankle obtained by a force of 200 N and by the maximal tolerated force applied to gastrocnemius muscles).
Pre-intervention (Day 1); After intervention (Day 1); Follow up (1 week after intervention).
Change in Ratio Hmax/Mmax.
Time Frame: Pre-intervention (Day 1); After intervention (Day 1); Follow up (1 week after intervention).
Ratio between maximal H-reflex and maximal M-wave.
Pre-intervention (Day 1); After intervention (Day 1); Follow up (1 week after intervention).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Maximal voluntary isometric force.
Time Frame: Pre-intervention (Day 1); After intervention (Day 1); Follow up (1 week after intervention).
Maximal voluntary isometric force test of Triceps Surae muscle and Tibialis Anterior muscle.
Pre-intervention (Day 1); After intervention (Day 1); Follow up (1 week after intervention).
Change in H reflex.
Time Frame: Pre-intervention (Day 1); After intervention (Day 1); Follow up (1 week after intervention).
Maximal H reflex, H reflex threshold and normalized H at 25% Mmax.
Pre-intervention (Day 1); After intervention (Day 1); Follow up (1 week after intervention).
Change in M response.
Time Frame: Pre-intervention (Day 1); After intervention (Day 1); Follow up (1 week after intervention).
Maximal M wave and M wave threshold.
Pre-intervention (Day 1); After intervention (Day 1); Follow up (1 week after intervention).

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain perception after intervention using Visual analogical scale.
Time Frame: After intervention (Day 1).
Pain perception after intervention using Visual analogical scale (VAS).
After intervention (Day 1).
Number of Local twitch responses.
Time Frame: During intervention (Day 1).
Number of local twitch responses during intervention.
During intervention (Day 1).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2015

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

June 1, 2017

Study Registration Dates

First Submitted

October 9, 2015

First Submitted That Met QC Criteria

October 12, 2015

First Posted (Estimate)

October 14, 2015

Study Record Updates

Last Update Posted (Actual)

October 20, 2017

Last Update Submitted That Met QC Criteria

October 18, 2017

Last Verified

October 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 83

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle Tone Abnormalities

Clinical Trials on Intervention-Dry Needling

3
Subscribe